tetano
Editor, Senior Moderator
Infect Control Hosp Epidemiol
. 2023 Aug 2;1-4.
doi: 10.1017/ice.2023.154. Online ahead of print. A review of extended coronavirus disease 2019 (COVID-19) isolation duration among inpatients in a tertiary-care hospital-Iowa, 2020-2022
Oluchi J Abosi[SUP] 1 [/SUP], Alexandra Trannel[SUP] 1 [/SUP], Patrick Schwartzhoff[SUP] 1 [/SUP], Mark Ackman[SUP] 1 [/SUP], Barbara Zilles[SUP] 1 [/SUP], Alexandre R Marra[SUP] 1 2 [/SUP], Angelique Dains[SUP] 1 [/SUP], Toshio Naito[SUP] 3 [/SUP], Jorge L Salinas[SUP] 4 [/SUP], Daniel J Diekema[SUP] 1 [/SUP], Beth Hanna[SUP] 1 [/SUP], Jaime P Murphy[SUP] 1 [/SUP], Melanie Wellington[SUP] 1 [/SUP], Karen Brust[SUP] 1 [/SUP], Takaaki Kobayashi[SUP] 1 3 [/SUP]
Affiliations
Of the 2,668 patients admitted with coronavirus disease 2019 (COVID-19), 4% underwent prolonged isolation for >20 days. Reasons for extended isolation were inconsistent with Centers for Disease Control and Prevention (CDC) guidelines in 25% of these patients and were questionable in 54% due to an ongoing critically ill condition at day 20 without CDC-defined immunocompromised status.
. 2023 Aug 2;1-4.
doi: 10.1017/ice.2023.154. Online ahead of print. A review of extended coronavirus disease 2019 (COVID-19) isolation duration among inpatients in a tertiary-care hospital-Iowa, 2020-2022
Oluchi J Abosi[SUP] 1 [/SUP], Alexandra Trannel[SUP] 1 [/SUP], Patrick Schwartzhoff[SUP] 1 [/SUP], Mark Ackman[SUP] 1 [/SUP], Barbara Zilles[SUP] 1 [/SUP], Alexandre R Marra[SUP] 1 2 [/SUP], Angelique Dains[SUP] 1 [/SUP], Toshio Naito[SUP] 3 [/SUP], Jorge L Salinas[SUP] 4 [/SUP], Daniel J Diekema[SUP] 1 [/SUP], Beth Hanna[SUP] 1 [/SUP], Jaime P Murphy[SUP] 1 [/SUP], Melanie Wellington[SUP] 1 [/SUP], Karen Brust[SUP] 1 [/SUP], Takaaki Kobayashi[SUP] 1 3 [/SUP]
Affiliations
- PMID: 37528757
- DOI: 10.1017/ice.2023.154
Of the 2,668 patients admitted with coronavirus disease 2019 (COVID-19), 4% underwent prolonged isolation for >20 days. Reasons for extended isolation were inconsistent with Centers for Disease Control and Prevention (CDC) guidelines in 25% of these patients and were questionable in 54% due to an ongoing critically ill condition at day 20 without CDC-defined immunocompromised status.